Subdural Hematoma clinical trials at University of California Health

1 research study open to eligible people

Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma
open to eligible people ages 18-90
The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the Onyx™ Liquid Embolic System (LES) for treatment of symptomatic subacute or chronic subdural hematoma (SDH)
at UC Irvine UCSD UCSF

Last updated: February 6, 2024